89bio, Inc.

Pharmaceutical Preparations·SAN FRANCISCO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2025	6/30/25	8/8/25	→
10-Q	Q1 2025	3/31/25	5/2/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/5/24	→
10-Q	Q1 2024	3/31/24	5/9/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
8/7/25	Q3 FY2025	→
5/1/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
1/13/25	Q4 FY2025	→
11/7/24	Q4 FY2024	→
8/5/24	Q2 FY2024	→
↓

News (8-K)

50 shown

Filed	Type	Description
10/30/25	Delisting	Termination of a Material Definitive Agreement	→
9/18/25	Agreement	Entry into a Material Definitive Agreement	→
5/30/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/9/25	Reg FD	Regulation FD Disclosure	→
2/4/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/29/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
10/30/25	POSASR	POSASR	→
10/30/25	POSASR	POSASR	→
10/30/25	S-8 POS	S-8 POS	→
10/30/25	S-8 POS	S-8 POS	→
10/30/25	S-8 POS	S-8 POS	→
10/30/25	S-8 POS	S-8 POS	→
↓

Filing History(559 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000712

—

11.0 KB

EFFECT

Nov 19, 2025

9999999995-25-003316

—

1.7 KB

SCHEDULE 13G

Nov 14, 2025

0000902664-25-005057

—

15.5 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-004825

—

11.1 KB

SCHEDULE 13G/A

Nov 13, 2025

0000919574-25-006756

—

16.5 KB

15-12G

Nov 10, 2025

0001193125-25-27316815-12G

—

11.1 KB

SCHEDULE 13D/A

Nov 3, 2025

0001346824-25-000037

—

19.1 KB

Nov 3, 2025

0001231919-25-000402

Oct 30, 2025

37.5 KB

SCHEDULE 13D/A

Oct 31, 2025

0000902664-25-004684

—

14.9 KB

Oct 30, 2025

0001193125-25-2590694

Oct 30, 2025

17.3 KB

Oct 30, 2025

0001193125-25-2590644

Oct 30, 2025

32.5 KB

Oct 30, 2025

0001193125-25-2590594

Oct 30, 2025

23.0 KB

Oct 30, 2025

0001193125-25-2590564

Oct 30, 2025

21.6 KB

Oct 30, 2025

0001193125-25-2590544

Oct 30, 2025

27.3 KB

Oct 30, 2025

0001193125-25-2590534

Oct 30, 2025

12.7 KB

Oct 30, 2025

0001193125-25-2590474

Oct 30, 2025

15.3 KB

Oct 30, 2025

0001193125-25-2590464

Oct 30, 2025

19.5 KB

Oct 30, 2025

0001193125-25-2590454

Oct 30, 2025

33.0 KB

Oct 30, 2025

0001193125-25-2590404

Oct 30, 2025

11.0 KB

Oct 30, 2025

0001193125-25-2590384

Oct 30, 2025

22.5 KB

Oct 30, 2025

0001193125-25-2590374

Oct 30, 2025

13.3 KB

Oct 30, 2025

0001193125-25-2590344

Oct 30, 2025

27.0 KB

POSASR

Oct 30, 2025

0001193125-25-258734POSASR

—

22.4 KB

POSASR

Oct 30, 2025

0001193125-25-258731POSASR

—

22.4 KB

POS AM

Oct 30, 2025

0001193125-25-258723POS AM

—

22.3 KB

25 filings shown

Filed	Form	Description
4/15/25	DEFA14A	DEFA14A	→
4/15/25	DEF 14A	DEF 14A	→
4/17/24	DEFA14A	DEFA14A	→
4/17/24	DEF 14A	DEF 14A	→
4/24/23	DEFA14A	DEFA14A	→
4/24/23	DEF 14A	DEF 14A	→
↓

89bio, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(559 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/3/25	4	4	→
10/30/25	4	4	→
10/30/25	4	4	→
10/30/25	4	4	→
10/30/25	4	4	→
10/30/25	4	4	→
↓

Filed	Form	Description
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/19/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/10/25	15-12G	15-12G	→
↓